Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision history now shows a new revision entry for v3.7.0 and removes the previous v3.6.6, reflecting an update to the page's revision history.SummaryDifference0.0%

- Check37 days agoChange DetectedHistory now shows a new entry Revision: v3.6.6. The previous entry Revision: v3.6.5 has been removed.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a deployment of the latest platform version. No study data or history entries were modified.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new software release. This update does not modify any study data or the history content.SummaryDifference0.0%

- Check95 days agoChange DetectedThe revision tag in the page footer updates from v3.6.2 to v3.6.3, signaling a new UI release without altering the study record content.SummaryDifference0.0%

- Check102 days agoChange DetectedA new site revision label v3.6.2 was added and the previous v3.6.0 entry was removed from the history display.SummaryDifference0.0%

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.